Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[Here, we demonstrate that erlotinib-induced cell growth inhibition in EGFR high-expressing human H322 NSCLC cells was accompanied by G1/S phase arrest, which was largely caused by a decrease in expression of G1/S-related cyclins, suppression of activities of cyclin-dependent kinase (CDK) 2 and CDK4, induction of CDK inhibitor p27(KIP1), and retinoblastoma hypophosphorylation.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• NP261974.RAcNqOvb9Qe5nBV6KRAQ3YLZ5QfmwbsOYAap7cqYvSBlc130_assertion description "[Here, we demonstrate that erlotinib-induced cell growth inhibition in EGFR high-expressing human H322 NSCLC cells was accompanied by G1/S phase arrest, which was largely caused by a decrease in expression of G1/S-related cyclins, suppression of activities of cyclin-dependent kinase (CDK) 2 and CDK4, induction of CDK inhibitor p27(KIP1), and retinoblastoma hypophosphorylation.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP261974.RAcNqOvb9Qe5nBV6KRAQ3YLZ5QfmwbsOYAap7cqYvSBlc130_provenance.
• NP886143.RACItBp3RYc6R_biLolt4vfIMlBFMgeEJAmSZETtJ1c9E130_assertion description "[Here, we demonstrate that erlotinib-induced cell growth inhibition in EGFR high-expressing human H322 NSCLC cells was accompanied by G1/S phase arrest, which was largely caused by a decrease in expression of G1/S-related cyclins, suppression of activities of cyclin-dependent kinase (CDK) 2 and CDK4, induction of CDK inhibitor p27(KIP1), and retinoblastoma hypophosphorylation.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP886143.RACItBp3RYc6R_biLolt4vfIMlBFMgeEJAmSZETtJ1c9E130_provenance.
• NP449801.RAdVTcnpQqUTt4Ti0rESP2QDOMAt3P6YLTLSzExdtHppc130_assertion description "[Here, we demonstrate that erlotinib-induced cell growth inhibition in EGFR high-expressing human H322 NSCLC cells was accompanied by G1/S phase arrest, which was largely caused by a decrease in expression of G1/S-related cyclins, suppression of activities of cyclin-dependent kinase (CDK) 2 and CDK4, induction of CDK inhibitor p27(KIP1), and retinoblastoma hypophosphorylation.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP449801.RAdVTcnpQqUTt4Ti0rESP2QDOMAt3P6YLTLSzExdtHppc130_provenance.
• NP937093.RAQO44EV9y5bdHYe2wZaf24cm-ZA-r7pSRCJm0I_2iFE0130_assertion description "[Here, we demonstrate that erlotinib-induced cell growth inhibition in EGFR high-expressing human H322 NSCLC cells was accompanied by G1/S phase arrest, which was largely caused by a decrease in expression of G1/S-related cyclins, suppression of activities of cyclin-dependent kinase (CDK) 2 and CDK4, induction of CDK inhibitor p27(KIP1), and retinoblastoma hypophosphorylation.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP937093.RAQO44EV9y5bdHYe2wZaf24cm-ZA-r7pSRCJm0I_2iFE0130_provenance.
• NP182515.RAiXrzjO60364bwtT1L3ttyll_W1IJfAaIqvGnThBWjRM130_assertion description "[Here, we demonstrate that erlotinib-induced cell growth inhibition in EGFR high-expressing human H322 NSCLC cells was accompanied by G1/S phase arrest, which was largely caused by a decrease in expression of G1/S-related cyclins, suppression of activities of cyclin-dependent kinase (CDK) 2 and CDK4, induction of CDK inhibitor p27(KIP1), and retinoblastoma hypophosphorylation.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP182515.RAiXrzjO60364bwtT1L3ttyll_W1IJfAaIqvGnThBWjRM130_provenance.
• NP570884.RApqd11WQXn78N8qH88xcldmSiyBL90lrtTiKfL8TKlO8130_assertion description "[Here, we demonstrate that erlotinib-induced cell growth inhibition in EGFR high-expressing human H322 NSCLC cells was accompanied by G1/S phase arrest, which was largely caused by a decrease in expression of G1/S-related cyclins, suppression of activities of cyclin-dependent kinase (CDK) 2 and CDK4, induction of CDK inhibitor p27(KIP1), and retinoblastoma hypophosphorylation.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP570884.RApqd11WQXn78N8qH88xcldmSiyBL90lrtTiKfL8TKlO8130_provenance.
• NP795192.RAgQSnYx-09ODRe09qFXlcM5HS9pV9A5IHXLy_4xNzrbM130_assertion description "[Here, we demonstrate that erlotinib-induced cell growth inhibition in EGFR high-expressing human H322 NSCLC cells was accompanied by G1/S phase arrest, which was largely caused by a decrease in expression of G1/S-related cyclins, suppression of activities of cyclin-dependent kinase (CDK) 2 and CDK4, induction of CDK inhibitor p27(KIP1), and retinoblastoma hypophosphorylation.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP795192.RAgQSnYx-09ODRe09qFXlcM5HS9pV9A5IHXLy_4xNzrbM130_provenance.
• NP366133.RA_ZFnD-rsFS69c8Hdbh48Yf851PPGYYEFTDLw8iLaKe8130_assertion description "[Here, we demonstrate that erlotinib-induced cell growth inhibition in EGFR high-expressing human H322 NSCLC cells was accompanied by G1/S phase arrest, which was largely caused by a decrease in expression of G1/S-related cyclins, suppression of activities of cyclin-dependent kinase (CDK) 2 and CDK4, induction of CDK inhibitor p27(KIP1), and retinoblastoma hypophosphorylation.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP366133.RA_ZFnD-rsFS69c8Hdbh48Yf851PPGYYEFTDLw8iLaKe8130_provenance.
• NP693553.RAa_A95jP4L367xpo630Cdp3EJbm5eeGpYvPCVZWNKOcc130_assertion description "[Here, we demonstrate that erlotinib-induced cell growth inhibition in EGFR high-expressing human H322 NSCLC cells was accompanied by G1/S phase arrest, which was largely caused by a decrease in expression of G1/S-related cyclins, suppression of activities of cyclin-dependent kinase (CDK) 2 and CDK4, induction of CDK inhibitor p27(KIP1), and retinoblastoma hypophosphorylation.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP693553.RAa_A95jP4L367xpo630Cdp3EJbm5eeGpYvPCVZWNKOcc130_provenance.
• NP390872.RA3BzxE583KAdIpnxsZvyfmj44TL4xUdIERUIyc3EqCHk130_assertion description "[Here, we demonstrate that erlotinib-induced cell growth inhibition in EGFR high-expressing human H322 NSCLC cells was accompanied by G1/S phase arrest, which was largely caused by a decrease in expression of G1/S-related cyclins, suppression of activities of cyclin-dependent kinase (CDK) 2 and CDK4, induction of CDK inhibitor p27(KIP1), and retinoblastoma hypophosphorylation.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP390872.RA3BzxE583KAdIpnxsZvyfmj44TL4xUdIERUIyc3EqCHk130_provenance.
• NP444782.RA_PjYUHDsCAdV1PjvyV1pnWKMBfAEgIvgfERsg763EWk130_assertion description "[Here, we demonstrate that erlotinib-induced cell growth inhibition in EGFR high-expressing human H322 NSCLC cells was accompanied by G1/S phase arrest, which was largely caused by a decrease in expression of G1/S-related cyclins, suppression of activities of cyclin-dependent kinase (CDK) 2 and CDK4, induction of CDK inhibitor p27(KIP1), and retinoblastoma hypophosphorylation.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP444782.RA_PjYUHDsCAdV1PjvyV1pnWKMBfAEgIvgfERsg763EWk130_provenance.
• NP301383.RARfVflyFS6mTw1pyhDlZcyfBz_JdZnm6J1dFAKiYw44k130_assertion description "[Here, we demonstrate that erlotinib-induced cell growth inhibition in EGFR high-expressing human H322 NSCLC cells was accompanied by G1/S phase arrest, which was largely caused by a decrease in expression of G1/S-related cyclins, suppression of activities of cyclin-dependent kinase (CDK) 2 and CDK4, induction of CDK inhibitor p27(KIP1), and retinoblastoma hypophosphorylation.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP301383.RARfVflyFS6mTw1pyhDlZcyfBz_JdZnm6J1dFAKiYw44k130_provenance.
• NP303424.RAc0cS31d5ojFCaiwh8pvqjNqGca4UaCuTthVQbubfHEA130_assertion description "[Here, we demonstrate that erlotinib-induced cell growth inhibition in EGFR high-expressing human H322 NSCLC cells was accompanied by G1/S phase arrest, which was largely caused by a decrease in expression of G1/S-related cyclins, suppression of activities of cyclin-dependent kinase (CDK) 2 and CDK4, induction of CDK inhibitor p27(KIP1), and retinoblastoma hypophosphorylation.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP303424.RAc0cS31d5ojFCaiwh8pvqjNqGca4UaCuTthVQbubfHEA130_provenance.
• NP845509.RAUvKJtqO1VhhF2KawAJzoGIo7t8eNCrlZmATgGt_WZo4130_assertion description "[Here, we demonstrate that erlotinib-induced cell growth inhibition in EGFR high-expressing human H322 NSCLC cells was accompanied by G1/S phase arrest, which was largely caused by a decrease in expression of G1/S-related cyclins, suppression of activities of cyclin-dependent kinase (CDK) 2 and CDK4, induction of CDK inhibitor p27(KIP1), and retinoblastoma hypophosphorylation.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP845509.RAUvKJtqO1VhhF2KawAJzoGIo7t8eNCrlZmATgGt_WZo4130_provenance.
• NP606324.RAVqMBPzm1C8dVdfaToS1J6u7zdKjJNE5mvODynrRRG04130_assertion description "[Here, we demonstrate that erlotinib-induced cell growth inhibition in EGFR high-expressing human H322 NSCLC cells was accompanied by G1/S phase arrest, which was largely caused by a decrease in expression of G1/S-related cyclins, suppression of activities of cyclin-dependent kinase (CDK) 2 and CDK4, induction of CDK inhibitor p27(KIP1), and retinoblastoma hypophosphorylation.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP606324.RAVqMBPzm1C8dVdfaToS1J6u7zdKjJNE5mvODynrRRG04130_provenance.
• NP606329.RAfKLQtS8Rg6QLToKcSA73Xy2FztL61buazH2fNy5_tc4130_assertion description "[Here, we demonstrate that erlotinib-induced cell growth inhibition in EGFR high-expressing human H322 NSCLC cells was accompanied by G1/S phase arrest, which was largely caused by a decrease in expression of G1/S-related cyclins, suppression of activities of cyclin-dependent kinase (CDK) 2 and CDK4, induction of CDK inhibitor p27(KIP1), and retinoblastoma hypophosphorylation.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP606329.RAfKLQtS8Rg6QLToKcSA73Xy2FztL61buazH2fNy5_tc4130_provenance.
• NP606330.RASuhqI3fi5d8gBxxiZeH0ur2wPL9TYCw8AOdqHzmEG2s130_assertion description "[Here, we demonstrate that erlotinib-induced cell growth inhibition in EGFR high-expressing human H322 NSCLC cells was accompanied by G1/S phase arrest, which was largely caused by a decrease in expression of G1/S-related cyclins, suppression of activities of cyclin-dependent kinase (CDK) 2 and CDK4, induction of CDK inhibitor p27(KIP1), and retinoblastoma hypophosphorylation.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP606330.RASuhqI3fi5d8gBxxiZeH0ur2wPL9TYCw8AOdqHzmEG2s130_provenance.
• NP771799.RALPil2XfynWmaXrtiD3J5DQ7KHsYfjr-LX7Q-8PL-7aE130_assertion description "[Here, we demonstrate that erlotinib-induced cell growth inhibition in EGFR high-expressing human H322 NSCLC cells was accompanied by G1/S phase arrest, which was largely caused by a decrease in expression of G1/S-related cyclins, suppression of activities of cyclin-dependent kinase (CDK) 2 and CDK4, induction of CDK inhibitor p27(KIP1), and retinoblastoma hypophosphorylation.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP771799.RALPil2XfynWmaXrtiD3J5DQ7KHsYfjr-LX7Q-8PL-7aE130_provenance.
• NP852359.RAFbX4qasVIO5z4yahDQQffqF8I9U6iM1aUPJpIJdtIQ4130_assertion description "[Here, we demonstrate that erlotinib-induced cell growth inhibition in EGFR high-expressing human H322 NSCLC cells was accompanied by G1/S phase arrest, which was largely caused by a decrease in expression of G1/S-related cyclins, suppression of activities of cyclin-dependent kinase (CDK) 2 and CDK4, induction of CDK inhibitor p27(KIP1), and retinoblastoma hypophosphorylation.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP852359.RAFbX4qasVIO5z4yahDQQffqF8I9U6iM1aUPJpIJdtIQ4130_provenance.
• NP606325.RAiUcWLkiIDddalXD9O6lXj4keC6qLrIGaYlr4gXkrP1U130_assertion description "[Here, we demonstrate that erlotinib-induced cell growth inhibition in EGFR high-expressing human H322 NSCLC cells was accompanied by G1/S phase arrest, which was largely caused by a decrease in expression of G1/S-related cyclins, suppression of activities of cyclin-dependent kinase (CDK) 2 and CDK4, induction of CDK inhibitor p27(KIP1), and retinoblastoma hypophosphorylation.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP606325.RAiUcWLkiIDddalXD9O6lXj4keC6qLrIGaYlr4gXkrP1U130_provenance.
• NP369036.RAOlpKi5NP3qIYLOgXo56v15x9rgyaYYE7kAWlLWzhTQo130_assertion description "[Here, we demonstrate that erlotinib-induced cell growth inhibition in EGFR high-expressing human H322 NSCLC cells was accompanied by G1/S phase arrest, which was largely caused by a decrease in expression of G1/S-related cyclins, suppression of activities of cyclin-dependent kinase (CDK) 2 and CDK4, induction of CDK inhibitor p27(KIP1), and retinoblastoma hypophosphorylation.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP369036.RAOlpKi5NP3qIYLOgXo56v15x9rgyaYYE7kAWlLWzhTQo130_provenance.
• NP606331.RA433PbWgtUTJnI6BwCUPKo5rOwSFenqZ0mQRHAVrHeeE130_assertion description "[Here, we demonstrate that erlotinib-induced cell growth inhibition in EGFR high-expressing human H322 NSCLC cells was accompanied by G1/S phase arrest, which was largely caused by a decrease in expression of G1/S-related cyclins, suppression of activities of cyclin-dependent kinase (CDK) 2 and CDK4, induction of CDK inhibitor p27(KIP1), and retinoblastoma hypophosphorylation.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP606331.RA433PbWgtUTJnI6BwCUPKo5rOwSFenqZ0mQRHAVrHeeE130_provenance.